JP2002506636A - ウイルスの伝播および増殖用の培地および方法 - Google Patents
ウイルスの伝播および増殖用の培地および方法Info
- Publication number
- JP2002506636A JP2002506636A JP2000536831A JP2000536831A JP2002506636A JP 2002506636 A JP2002506636 A JP 2002506636A JP 2000536831 A JP2000536831 A JP 2000536831A JP 2000536831 A JP2000536831 A JP 2000536831A JP 2002506636 A JP2002506636 A JP 2002506636A
- Authority
- JP
- Japan
- Prior art keywords
- virus
- medium
- propagation
- cells
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0043—Medium free of human- or animal-derived components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32651—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9803333A FR2775983B1 (fr) | 1998-03-13 | 1998-03-13 | Milieu et procede de propagation et de multiplication virales |
FR98/03333 | 1998-03-13 | ||
PCT/FR1999/000578 WO1999047648A2 (fr) | 1998-03-13 | 1999-03-15 | Milieu et procede de propagation et de multiplication virales |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002506636A true JP2002506636A (ja) | 2002-03-05 |
Family
ID=9524203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000536831A Withdrawn JP2002506636A (ja) | 1998-03-13 | 1999-03-15 | ウイルスの伝播および増殖用の培地および方法 |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1062324A2 (fr) |
JP (1) | JP2002506636A (fr) |
KR (1) | KR20010072556A (fr) |
CN (1) | CN1301297A (fr) |
AU (1) | AU752577B2 (fr) |
BR (1) | BR9908744A (fr) |
CA (1) | CA2322619A1 (fr) |
EA (1) | EA200000934A1 (fr) |
FR (1) | FR2775983B1 (fr) |
HU (1) | HUP0101081A3 (fr) |
IL (1) | IL138250A0 (fr) |
NZ (1) | NZ506872A (fr) |
PL (1) | PL343557A1 (fr) |
SK (1) | SK12882000A3 (fr) |
TR (1) | TR200002641T2 (fr) |
WO (1) | WO1999047648A2 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000083657A (ja) * | 1998-07-13 | 2000-03-28 | Chemo Sero Therapeut Res Inst | 日本脳炎ウイルスワクチン |
JP2005532057A (ja) * | 2002-07-09 | 2005-10-27 | バクスター・インターナショナル・インコーポレイテッド | 細胞を培養するための動物性タンパク質非含有培地 |
JP2010068734A (ja) * | 2008-09-17 | 2010-04-02 | Toyota Central R&D Labs Inc | 乳酸の製造方法及び乳酸発酵用添加剤 |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT409379B (de) | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
WO2002077206A1 (fr) * | 2001-03-27 | 2002-10-03 | Vertex Pharmaceuticals Incorporated | Composition et methodes de traitement de l'infection par le vhc |
GB0304799D0 (en) | 2003-03-03 | 2003-04-09 | Glaxosmithkline Biolog Sa | Novel method |
US20060094104A1 (en) | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
ES2474573T3 (es) | 2006-01-04 | 2014-07-09 | Baxter International Inc | Medio de cultivo celular sin oligop�ptidos |
CN107129963A (zh) * | 2017-04-24 | 2017-09-05 | 浙江美保龙生物技术有限公司 | 一种df‑1细胞培养液添加剂及其制备方法、使用方法 |
CN107043739A (zh) * | 2017-04-24 | 2017-08-15 | 浙江美保龙生物技术有限公司 | 一种Vero细胞培养液添加剂及其制备方法、使用方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5498537A (en) * | 1994-03-09 | 1996-03-12 | Cellco, Inc. | Serum-free production of packaged viral vector |
FR2732347A1 (fr) * | 1995-03-30 | 1996-10-04 | Bio Media | Extrait vegetal, son procede de preparation et ses applications en medecine humaine ou veterinaire |
WO1998046244A1 (fr) * | 1997-04-16 | 1998-10-22 | Feva N.V. | Extrait vegetal, procede de preparation associe, et utilisations en medecine humaine et veterinaire |
-
1998
- 1998-03-13 FR FR9803333A patent/FR2775983B1/fr not_active Expired - Fee Related
-
1999
- 1999-03-15 AU AU27352/99A patent/AU752577B2/en not_active Ceased
- 1999-03-15 CA CA 2322619 patent/CA2322619A1/fr not_active Abandoned
- 1999-03-15 TR TR200002641T patent/TR200002641T2/xx unknown
- 1999-03-15 BR BR9908744A patent/BR9908744A/pt not_active IP Right Cessation
- 1999-03-15 NZ NZ506872A patent/NZ506872A/en unknown
- 1999-03-15 IL IL13825099A patent/IL138250A0/xx unknown
- 1999-03-15 EA EA200000934A patent/EA200000934A1/ru unknown
- 1999-03-15 JP JP2000536831A patent/JP2002506636A/ja not_active Withdrawn
- 1999-03-15 PL PL34355799A patent/PL343557A1/xx not_active Application Discontinuation
- 1999-03-15 HU HU0101081A patent/HUP0101081A3/hu unknown
- 1999-03-15 SK SK1288-2000A patent/SK12882000A3/sk unknown
- 1999-03-15 CN CN99803965A patent/CN1301297A/zh active Pending
- 1999-03-15 EP EP99907713A patent/EP1062324A2/fr not_active Withdrawn
- 1999-03-15 KR KR1020007010026A patent/KR20010072556A/ko not_active Application Discontinuation
- 1999-03-15 WO PCT/FR1999/000578 patent/WO1999047648A2/fr not_active Application Discontinuation
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000083657A (ja) * | 1998-07-13 | 2000-03-28 | Chemo Sero Therapeut Res Inst | 日本脳炎ウイルスワクチン |
JP2005532057A (ja) * | 2002-07-09 | 2005-10-27 | バクスター・インターナショナル・インコーポレイテッド | 細胞を培養するための動物性タンパク質非含有培地 |
JP2011041580A (ja) * | 2002-07-09 | 2011-03-03 | Baxter Internatl Inc | 細胞を培養するための動物性タンパク質非含有培地 |
JP2012034712A (ja) * | 2002-07-09 | 2012-02-23 | Baxter Internatl Inc | 細胞を培養するための動物性タンパク質非含有培地 |
JP2013172741A (ja) * | 2002-07-09 | 2013-09-05 | Baxter Internatl Inc | 細胞を培養するための動物性タンパク質非含有培地 |
JP2015083005A (ja) * | 2002-07-09 | 2015-04-30 | バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated | 細胞を培養するための動物性タンパク質非含有培地 |
US9163211B2 (en) | 2002-07-09 | 2015-10-20 | Baxter International Inc. | Animal protein free media for cultivation of cells |
JP2010068734A (ja) * | 2008-09-17 | 2010-04-02 | Toyota Central R&D Labs Inc | 乳酸の製造方法及び乳酸発酵用添加剤 |
Also Published As
Publication number | Publication date |
---|---|
BR9908744A (pt) | 2000-12-26 |
IL138250A0 (en) | 2001-10-31 |
HUP0101081A3 (en) | 2003-04-28 |
CA2322619A1 (fr) | 1999-09-23 |
CN1301297A (zh) | 2001-06-27 |
KR20010072556A (ko) | 2001-07-31 |
PL343557A1 (en) | 2001-08-27 |
EA200000934A1 (ru) | 2001-02-26 |
EP1062324A2 (fr) | 2000-12-27 |
SK12882000A3 (sk) | 2001-05-10 |
TR200002641T2 (tr) | 2000-11-21 |
FR2775983A1 (fr) | 1999-09-17 |
AU2735299A (en) | 1999-10-11 |
NZ506872A (en) | 2002-03-01 |
WO1999047648A3 (fr) | 1999-11-04 |
FR2775983B1 (fr) | 2000-11-10 |
AU752577B2 (en) | 2002-09-26 |
HUP0101081A2 (hu) | 2001-07-30 |
WO1999047648A2 (fr) | 1999-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2488818T3 (es) | Método para la producción a gran escala de virus | |
EP2454364B1 (fr) | Production de poliovirus à des titres élevés pour la production de vaccins | |
JP6243333B2 (ja) | ワクシニアウィルスの生成のための方法および組成物 | |
KR20070060049A (ko) | 인플루엔자 백신의 제조방법 | |
US4664912A (en) | Process for the large scale production of rabies vaccine | |
PT1427815E (pt) | Métodos para a produção industrial de vacinas | |
JP2002506636A (ja) | ウイルスの伝播および増殖用の培地および方法 | |
CN109097341B (zh) | 一种同时表达ha和hef的复制缺陷型重组流感病毒 | |
KR20160019477A (ko) | 바이러스 성분의 어그리게이션을 저해하는 방법 | |
US9932562B2 (en) | Drain down and re-feed of microcarrier bioreactor | |
JPH08509369A (ja) | 哺乳類株化細胞および糖蛋白の生産方法 | |
CN111714626A (zh) | 一种采用mdck细胞系生产禽流感疫苗的方法及其制品 | |
CN116656628A (zh) | 一种痘病毒载体疫苗的制备方法 | |
CN113005100B (zh) | 一种改变囊膜病毒热稳定性的遗传改造方法及重组病毒与其应用 | |
CN107432931A (zh) | 一种微载体培养水痘病毒制备疫苗的方法 | |
CN108261543B (zh) | 传代细胞源nd、ib、ai三联灭活疫苗的制备方法及其应用 | |
CN103100083A (zh) | 疫苗及其制备方法 | |
TWI447226B (zh) | 用於增殖病毒之二步驟溫度型態 | |
CZ20003327A3 (cs) | Prostředí pro propagaci a multiplikaci virů a způsob propagace a multiplikace virů | |
CN117731652A (zh) | 一种狂犬病疫苗保护剂及含有其疫苗的制备方法 | |
US20100105108A1 (en) | Method and device for producing vaccine | |
JP2023500873A (ja) | 低減した粒度を有するウイルスワクチンを生成するための組成物および方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A300 | Application deemed to be withdrawn because no request for examination was validly filed |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20060606 |